NEW YORK (Reuters Health) Mar 01 – Apolipoprotein B (apoB) and small dense low-density lipoprotein (LDL) appear to be a better way to define familial combined hyperlipidemia (FCH) than current criteria, Dutch investigators suggest.
"FCH is characterized by a variable expression of hypercholesterolemia and/or hypertriglyceridemia," Dr. Mario J. Veerkamp and colleagues, from the University Medical Center Nijmegen, note in the February issue of Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.
The researchers examined variability in lipid phenotype expression over a 5-year period in subjects from 32 families classified as having FCH based on total cholesterol and/or triglyceride levels exceeding the 90th percentile after adjustment for age and sex.
At the start of the study, 93 (31%) of the subjects were affected and 206 (69%) were unaffected relatives. Five years later, "a diagnosis of FCH was consistent in 69 (74%) of the 93 subjects," the team reports. Hence, 26% of the FCH subjects showed a sporadic normolipidemic pattern.
Among the 206 unaffected relatives at the start of the study, 28 (14%) developed an FCH lipid phenotype over 5 years. …
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!